The difference in association between aspirin use and other thrombocyte aggregation inhibitors and survival in patients with colorectal cancer

MA Frouws; E Rademaker; E Bastiaannet; MPP van Herk-Sukel; Valery Lemmens; CJH van de Velde; JEA Portielje; GJ Liefers

doi:10.1016/j.ejca.2017.02.025

The difference in association between aspirin use and other thrombocyte aggregation inhibitors and survival in patients with colorectal cancer

MA Frouws, E Rademaker, E Bastiaannet, MPP van Herk-Sukel, Valery Lemmens, CJH van de Velde, JEA Portielje, GJ Liefers

Public Health

Research output: Contribution to journal › Article › Academic › peer-review

8 Citations (Scopus)

Original language	Undefined/Unknown
Pages (from-to)	24-30
Number of pages	7
Journal	European Journal of Cancer
Volume	77
DOIs	https://doi.org/10.1016/j.ejca.2017.02.025
Publication status	Published - 2017

Research programs

EMC OR-01

UN SDGs

This output contributes to the following UN Sustainable Development Goals (SDGs)

Access to Document

10.1016/j.ejca.2017.02.025

http://hdl.handle.net/1765/98788

Cite this

@article{6a50c6f5233841eda7beb8ef1aa29004,

title = "The difference in association between aspirin use and other thrombocyte aggregation inhibitors and survival in patients with colorectal cancer",

author = "MA Frouws and E Rademaker and E Bastiaannet and {van Herk-Sukel}, MPP and Valery Lemmens and {van de Velde}, CJH and JEA Portielje and GJ Liefers",

year = "2017",

doi = "10.1016/j.ejca.2017.02.025",

language = "Undefined/Unknown",

volume = "77",

pages = "24--30",

journal = "European Journal of Cancer",

issn = "0959-8049",

publisher = "Elsevier Ltd.",

}

TY - JOUR

T1 - The difference in association between aspirin use and other thrombocyte aggregation inhibitors and survival in patients with colorectal cancer

AU - Frouws, MA

AU - Rademaker, E

AU - Bastiaannet, E

AU - van Herk-Sukel, MPP

AU - Lemmens, Valery

AU - van de Velde, CJH

AU - Portielje, JEA

AU - Liefers, GJ

PY - 2017

Y1 - 2017

U2 - 10.1016/j.ejca.2017.02.025

DO - 10.1016/j.ejca.2017.02.025

M3 - Article

C2 - 28350995

SN - 0959-8049

VL - 77

SP - 24

EP - 30

JO - European Journal of Cancer

JF - European Journal of Cancer

ER -